# Selective Serotonin Reuptake Inhibitor Toxicity

SSRI overdose is usually mild but can produce serotonin toxicity, delayed seizures, QTc or QRS prolongation, dysrhythmia, and rhabdomyolysis. Triage hinges on exposure history, clonus-focused examination, serial ECG assessment, co-ingestant evaluation, supportive treatment, and prolonged monitoring when escitalopram or citalopram is involved.

**Clinical question:** How should clinicians identify, risk-stratify, monitor, and manage acute selective serotonin reuptake inhibitor toxicity?

Updated: 2026-09-16T00:09:04.467807+00:00

## What matters in practice
- In a patient with serotonergic exposure, inducible, spontaneous, or generalized clonus is the most actionable examination finding supporting serotonin toxicity; lower-extremity findings may be most prominent. [24]
- Obtain an ECG and continue cardiac monitoring when escitalopram overdose is suspected because delayed QRS/QTc prolongation, wide-complex tachyarrhythmia, and torsade de pointes have been reported. [1][2]
- Stop serotonergic agents, use benzodiazepines for agitation and neuromuscular hyperexcitability, and treat hyperthermia with active cooling and escalation of airway/critical care support when severe toxicity develops. [9][17]
- Check creatine kinase at presentation and repeat it during admission when severe agitation, rigidity, seizures, or hyperthermia occur; rhabdomyolysis may be delayed despite an initially normal CK. [17][20]
- Early activated charcoal is an option after escitalopram overdose, but poison-center or medical-toxicology consultation should guide decontamination and disposition. [1][2]

## Identify immediate threats and the exposure pattern

Treat instability first while defining the agent, formulation, dose, time, and co-ingestants.

Prioritize airway protection, oxygenation, temperature control, circulation, and seizure treatment in any patient with depressed consciousness, hyperthermia, marked agitation, rigidity, or dysrhythmia. SSRI poisoning is often limited to nausea, vomiting, or drowsiness, but serotonin syndrome, seizures, and QT prolongation occur in a minority; ICU admission and death are uncommon overall. [11]

Establish whether exposure is isolated or mixed. Severe serotonin toxicity is more likely with serotonergic polypharmacy, including another antidepressant, monoamine oxidase inhibitor, certain opioids, triptan, over-the-counter cough/cold product, antiemetic, or drug of abuse. Concomitant MAOI exposure is particularly concerning because serious and sometimes fatal reactions with hyperthermia, rigidity, myoclonus, autonomic instability, delirium, coma, and rapid vital-sign fluctuations have been reported. [3][4][9][14]

Obtain the home medication list, refill history when available, pill counts, formulation, time of ingestion, intentionality, and all co-ingestants. Escitalopram and citalopram warrant particular cardiac attention because both are associated with QTc prolongation; escitalopram labeling also reports delayed seizures, altered mental status, QRS/QTc prolongation, wide-complex tachyarrhythmias, and torsade de pointes in overdose. [1][2][24]
- Call Poison Help at 1-800-222-1222 or consult a medical toxicologist early for clinically significant overdose, uncertain exposure, co-ingestion, ECG abnormality, seizure, or serotonin toxicity. [1][2]
- Assess intentional exposures for self-harm risk once medically stabilized; intentional overdose accounted for 76% of reported serotonin-toxicity cases in one series. [17]

*Immediate risk features that should change monitoring intensity or level of care. [1][2][17][20][24]*

| Finding | Interpretation | Immediate next step |
| --- | --- | --- |
| Generalized clonus, hyperreflexia, myoclonus, agitation, diaphoresis, tachycardia | Serotonin toxicity is likely in the setting of serotonergic exposure. [17][24] | Stop serotonergic agents; administer benzodiazepines for agitation or neuromuscular excitation; monitor temperature and cardiorespiratory status. [9][17] |
| Hyperthermia, severe rigidity, declining consciousness, seizure | Severe toxicity with risk for rhabdomyolysis, respiratory compromise, and multiorgan dysfunction. [9][17][20] | Initiate active cooling, manage airway as needed, obtain CK and renal-function testing, give intravenous fluids when rhabdomyolysis is a concern, and admit to critical care. [9][20] |
| QTc or QRS prolongation, wide-complex rhythm, ventricular dysrhythmia | Potential delayed cardiotoxicity, especially after escitalopram exposure. [1][2][22] | Continue cardiac monitoring and obtain toxicology input; sodium bicarbonate improved QRS prolongation in a reported escitalopram overdose case. [1][2][22] |
| Normal initial CK after a large overdose or severe neuromuscular findings | Does not exclude evolving rhabdomyolysis. [20] | Repeat CK during admission and continue clinical surveillance for muscle injury and renal complications. [20] |

## Diagnose serotonin toxicity clinically and separate key mimics

No laboratory test confirms serotonin toxicity; the examination and exposure timeline drive diagnosis.

Perform a focused neurologic examination before sedation when feasible: assess ocular and lower-extremity clonus, deep-tendon reflexes, tremor, tone, coordination, mental status, pupils, diaphoresis, bowel activity, and temperature. Serotonin toxicity is a clinical diagnosis requiring serotonergic exposure or overdose plus compatible neuromuscular excitation, autonomic stimulation, and altered consciousness; generalized clonus is a particularly discriminating finding, and neuromuscular signs may be most evident in the legs. [24]

Use the Hunter serotonin-toxicity framework rather than relying on nonspecific symptoms alone. In the setting of serotonergic exposure, diagnostic constellations include spontaneous clonus; inducible clonus plus agitation or diaphoresis; ocular clonus plus agitation or diaphoresis; tremor plus hyperreflexia; or hypertonia plus temperature above 38°C with ocular or inducible clonus. [23][24]

Differentiate serotonin toxicity from neuroleptic malignant syndrome–like reactions by medication history and neuromuscular pattern. SSRI labeling recognizes that severe serotonin syndrome can resemble neuroleptic malignant syndrome, including hyperthermia, rigidity, autonomic instability, and altered mental status; clonus and hyperreflexia support serotonergic toxicity and should redirect treatment toward serotonergic drug cessation and sedation. [3][4][24]

Do not attribute coma, marked acidosis, persistent seizure, conduction abnormality, or disproportionate hypotension to an uncomplicated isolated SSRI exposure without reassessing for co-ingestants or alternative diagnoses. Escitalopram overdose labeling specifically notes that hypotension may occur, particularly with co-ingestants including alcohol. [1][2]
- Obtain a 12-lead ECG in clinically significant SSRI overdose, especially after citalopram or escitalopram exposure. [1][2][24]
- Measure CK at presentation when rigidity, hyperthermia, prolonged agitation, or seizure is present and repeat it when the clinical course remains severe or evolves. [17][20]
- Use serial examinations rather than a single normal assessment when the ingestion is recent, because seizures, cardiac toxicity, and rhabdomyolysis may be delayed. [1][2][20]

*Focused differentiation of serotonergic toxicity from competing drug syndromes. [3][4][9][24]*

| Syndrome | Exposure clue | Examination discriminator | Management implication |
| --- | --- | --- | --- |
| Serotonin toxicity | SSRI overdose or combination with serotonergic drugs or MAOIs. [3][4][9] | Clonus and hyperreflexia, often prominent in lower extremities. [24] | Stop serotonergic drugs; sedate with benzodiazepines and treat hyperthermia aggressively. [9][17] |
| NMS-like reaction | Antipsychotic or dopamine-antagonist exposure may coexist with SSRI therapy. [3][4] | Can share rigidity, hyperthermia, autonomic instability, and altered mental status; absence of clonus should prompt reconsideration. [3][4][24] | Do not assume serotonin toxicity solely from fever and rigidity; re-evaluate the medication timeline and full toxidrome. [3][4] |
| SSRI discontinuation syndrome | Abrupt interruption of chronic SSRI therapy rather than overdose. [19] | Dizziness, nausea, tremor, anxiety, and insomnia can overlap with toxicity symptoms but lack the exposure pattern of excess serotonergic drug effect. [5][19] | Confirm adherence and recent dose changes before treating presumed serotonergic poisoning. [19] |

## Treat agitation, hyperthermia, seizures, and dysrhythmia supportively

Management is driven by physiologic severity, not serum drug concentration.

Immediately discontinue all serotonergic agents when serotonin toxicity is suspected. Provide intravenous fluids as clinically indicated, active external cooling for hyperthermia, and short-acting benzodiazepines for agitation and neuromuscular hyperexcitability; benzodiazepines were used in 67% of reported serotonin-toxicity cases. [9][17]

Escalate to ICU-level care for hyperthermia, escalating rigidity, recurrent seizure, impaired airway protection, ventilatory support, shock, clinically important ECG abnormalities, or progressive rhabdomyolysis. Severe serotonin toxicity can progress to seizures and multiorgan dysfunction, and a pediatric sertraline overdose case required mechanical ventilation and neuromuscular paralysis for severe illness with progressive rhabdomyolysis. [9][14]

Cyproheptadine has been used as a nonspecific serotonin antagonist, but reported practice is variable: only 15.1% of patients in one 1,010-case series received it. Consider toxicology-guided use for persistent clinically significant serotonin toxicity despite drug cessation, sedation, and supportive measures rather than substituting it for resuscitation, cooling, or airway management. [14][17]

Treat seizures promptly with benzodiazepines and monitor for recurrence because seizures may be delayed after escitalopram overdose. For QRS widening or right bundle branch block after escitalopram overdose, one reported case improved after sodium bicarbonate; persistent ECG abnormalities require continuous monitoring and toxicology-directed management. [1][2][22]
- Consider activated charcoal only for patients presenting early after escitalopram overdose and only after assessing airway protection and aspiration risk. [1][2]
- Do not delay active cooling for confirmatory testing when hyperthermia accompanies rigidity or clonus. [9][17]
- Avoid adding serotonergic medications during acute management, particularly in a patient with suspected mixed serotonergic ingestion. [3][4][9]

### Rhabdomyolysis surveillance

Obtain repeat CK testing after severe SSRI toxicity even if the initial value is normal. In a fluoxetine overdose case, CK was normal on arrival, rose rapidly at 36 hours, and peaked at 74 hours; early fluid replacement was identified as important to reduce renal-failure risk. [20]
- Pair repeat CK assessment with renal-function and urine-output monitoring when rhabdomyolysis is present or suspected. [20]
- Continue intravenous fluid therapy when clinically indicated by evolving muscle injury or renal-risk assessment. [20]

*Severity-directed treatment priorities in SSRI toxicity. [1][2][9][14][17][20][22]*

| Clinical branch | Treatment priority | Monitoring or escalation trigger |
| --- | --- | --- |
| Mild gastrointestinal or sedating effects without clonus, seizure, or ECG abnormality | Supportive observation and reassessment for evolving serotonergic findings. [11][24] | Escalate if agitation, clonus, hyperthermia, seizure, or ECG changes develop. [1][2][24] |
| Serotonin toxicity with agitation, tremor, clonus, or hyperreflexia | Stop serotonergic agents; give benzodiazepines and supportive care. [9][17] | Serial neurologic, temperature, and cardiorespiratory assessment; ICU if severe progression occurs. [9][17] |
| Hyperthermia, rigidity, seizures, or depressed consciousness | Active cooling, benzodiazepines, airway and critical-care support as required; assess for rhabdomyolysis. [9][14][20] | ICU-level monitoring; repeat CK because delayed elevation can occur. [17][20] |
| Escitalopram-associated QRS/QTc prolongation or dysrhythmia | Continuous cardiac monitoring and toxicology consultation; sodium bicarbonate may be considered for QRS widening based on a reported case. [1][2][22] | Monitor for delayed wide-complex tachyarrhythmia or torsade de pointes. [1][2] |

## Use serial findings to determine observation, admission, and clearance

Disposition should reflect delayed neurologic, cardiac, and muscle-injury complications.

Maintain prolonged cardiac monitoring after escitalopram overdose because the labeling specifically recommends it for arrhythmia risk and reports delayed QRS/QTc prolongation, wide-complex tachyarrhythmias, and torsade de pointes. A normal initial ECG should therefore not override a clinically significant exposure history or evolving symptoms. [1][2]

Admit patients with serotonin toxicity requiring repeated benzodiazepines, hyperthermia, seizure, altered consciousness, ECG abnormalities, or rising CK. In reported serotonin-toxicity cases, rhabdomyolysis occurred in 9.7%, seizures in 13.7%, dysrhythmias in 0.8%, and death in 0.1%; these figures describe a selected toxicology case series rather than risk for every SSRI exposure. [17]

Before medical clearance after intentional ingestion, ensure that neurologic findings have resolved, temperature and vital signs are stable, ECG concerns have been addressed, and CK surveillance is complete when symptoms suggested muscle injury. Arrange psychiatric assessment and a medication-safety plan after the acute toxicologic risk has resolved. Intentional exposures predominated in the reported serotonin-toxicity cohort. [17][20]
- Repeat the ECG if symptoms evolve or an initial tracing shows QRS or QTc abnormality. [1][2][22]
- Repeat CK later in admission after severe fluoxetine or other SSRI toxicity with seizure, rigidity, hyperthermia, or prolonged agitation. [20]
- Avoid restarting serotonergic therapy until the acute toxidrome has resolved and the interaction or overdose context has been reviewed. [3][4][9]

*Monitoring targets after clinically significant SSRI exposure. [1][2][17][20][24]*

| Target | Who needs it | What changes management |
| --- | --- | --- |
| Serial neurologic examination | Any patient with suspected serotonin toxicity or recent substantial ingestion. [24] | New clonus, hyperreflexia, rigidity, agitation, or declining consciousness warrants escalation of sedation and level of care. [9][17][24] |
| Temperature monitoring | Patients with clonus, agitation, rigidity, diaphoresis, or autonomic instability. [9][24] | Hyperthermia requires active cooling and critical-care assessment. [9][17] |
| Continuous cardiac monitoring and serial ECG | Escitalopram overdose and patients with conduction or repolarization abnormalities. [1][2] | QRS/QTc progression, wide-complex rhythm, or torsade de pointes risk requires ongoing monitored care and toxicology involvement. [1][2][22] |
| CK reassessment | Seizure, rigidity, hyperthermia, prolonged agitation, or large overdose. [17][20] | A delayed CK rise supports continued fluids and renal-risk monitoring. [20] |

## Common questions

### Does coprescription of a triptan with an SSRI usually require avoidance?

No. In a large coprescription study, serotonin syndrome was rare among patients receiving both a triptan and an SSRI or SNRI. Counsel patients about symptoms and reassess risk when additional serotonergic agents, overdose, or an MAOI is involved. [7][3][4]

### Which SSRI overdose should prompt particular concern for cardiac toxicity?

Citalopram and escitalopram are associated with QTc prolongation; escitalopram overdose labeling also reports delayed QRS/QTc prolongation, wide-complex tachyarrhythmias, and torsade de pointes and recommends prolonged cardiac monitoring. [1][2][24]

## References
1. [PDF] LEXAPRO - DailyMed — dailymed.nlm.nih.gov — https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=13bb8267-1cab-43e5-acae-55a4d957630a
2. These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002 — dailymed.nlm.nih.gov — https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=5088d6cd-ec13-384d-e063-6394a90aee05&type=display
3. CITALOPRAM TABLETS USP474047414742Rx only — www.dailymed.nlm.nih.gov — https://www.dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=871a7ee6-f420-427b-b0e1-b5516d7e1593&type=display
4. [PDF] ESCITALOPRAM - DailyMed — www.dailymed.nlm.nih.gov — https://www.dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=2a33f95e-4245-4437-86a9-fcfc87e26edb&type=pdf
5. Effects of Exposure to Selective Serotonin Reuptake Inhibitors ... — jamanetwork.com — https://jamanetwork.com/journals/jamapsychiatry/fullarticle/207591
6. Use of Selective Serotonin Reuptake Inhibitors and Risk of Upper ... — jamanetwork.com — https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/214901
7. Association of Coprescription of Triptan Antimigraine Drugs — jamanetwork.com — https://jamanetwork.com/journals/jamaneurol/articlepdf/10.1001/jamaneurol.2017.5144
8. Risk of Opioid Overdose With Concomitant Use of Oxycodone and ... — jamanetwork.com — https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2789401
9. Serotonin Toxicity and Clinical Management | Toxicology | Pharmacology and Pharmaceutical Sciences | Health sciences | Topics | Nature Index — www.nature.com — https://www.nature.com/nature-index/topics/l4/serotonin-toxicity-and-clinical-management
10. Catecholamine-Mediated Pathways in Takotsubo Syndrome: Does it Matter If it Is a Serotonin Norepinephrine Reuptake Inhibitor or a Selective Serotonin Reuptake Inhibitor? — www.jacc.org — https://www.jacc.org/doi/10.1016/j.jchf.2018.04.016
11. Clinical toxicity and management of selective serotonin reuptake inhibitor (SSRI) poisoning: a comprehensive review — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S2667118226000085
12. Two Cases of Serotonin Syndrome After Bupropion Overdose Treated With Cyproheptadine - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0736467920310878
13. Ssri-related toxic serotonin syndrome: improvement by discontinuation of treatment and propranolol - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0924933897847955
14. Serotonin Syndrome after Sertraline Overdose in a Child: A Case Report - Grenha - 2013 - Case Reports in Pediatrics - Wiley Online Library — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1155/2013/897902
15. Serotonin Syndrome Associated With Vilazodone Overdose in a 22-Month-Old Treated With Dexmedetomidine - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0736467920310568
16. Selective serotonin reuptake inhibitor (SSRI) toxicosis in cats: 33 ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1111/vec.12091
17. Serotonin Toxicity : Journal of Clinical Psychopharmacology — journals.lww.com — https://journals.lww.com/psychopharmacology/fulltext/2019/11000/serotonin_toxicity__associated_agents_and_clinical.15.aspx
18. Adult Toxicology in Critical Carea - CHEST Journal — journal.chestnet.org — https://journal.chestnet.org/article/S0012-3692(16)34761-4/fulltext
19. Selective Serotonin Reuptake Inhibitor Antidepressant Treatment Discontinuation Syndrome: A Review of the Clinical Evidence and the Possible Mechanisms Involved - PMC — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627130
20. Fluoxetine overdose in a teenager resulting in serotonin syndrome, seizure and delayed onset rhabdomyolysis - PMC — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194370
21. The anaesthetist, opioid analgesic drugs, and serotonin toxicity - Ovid — www.bjanaesthesia.org — https://www.bjanaesthesia.org/article/S0007-0912(19)30632-4/pdf
22. 2023 ACMT Annual Scientific Meeting Abstracts – San Diego, CA - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC10035466
23. The pharmacokinetics of sertraline in overdose and the effect of activated charcoal — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC4309636
24. Selective Serotonin Reuptake Inhibitor Toxicity - StatPearls - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK534815

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.